Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04324021
Brief Title: Efficacy and Safety of Emapalumab and Anakinra in Reducing Hyperinflammation and Respiratory Distress in Patients With COVID-19 Infection.

First Submitted : March 25, 2020
First Submitted that Met QC Criteria : March 25, 2020
First Posted : March 27, 2020

Results First Submitted : November 29, 2021
Results First Posted with QC Comments : December 2, 2021
Results First Submitted that Met QC Criteria : March 3, 2022
Results First Posted : March 10, 2022

Last Update Submitted that Met QC Criteria : March 3, 2022
Last Update Posted : March 10, 2022